Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia

[1]  E. Rojas,et al.  Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  K. Matsuno,et al.  Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. , 1993, The Journal of pharmacology and experimental therapeutics.

[3]  W. Schmidt,et al.  The σ receptor ligand 1,3-di-(2-tolyl) guanidine in animal models of schizophrenia , 1993 .

[4]  T. Kameyama,et al.  Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia. , 1992, European journal of pharmacology.

[5]  W. Bowen,et al.  Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study , 1992, Brain Research.

[6]  G. Debonnel,et al.  In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. , 1992, The Journal of pharmacology and experimental therapeutics.

[7]  K. Matsuno,et al.  Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis , 1992, Brain Research.

[8]  T. Su,et al.  Sigma receptors. Putative links between nervous, endocrine and immune systems. , 1991, European journal of biochemistry.

[9]  S. Snyder,et al.  σ Receptors: From Molecule to Man , 1991 .

[10]  I. Izquierdo,et al.  Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection , 1991, Brain Research.

[11]  B. Leonard,et al.  Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor , 1991, Brain Research.

[12]  T. Kameyama,et al.  Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. , 1991, European journal of pharmacology.

[13]  W. Bowen,et al.  Sigma receptors: biology and function. , 1990, Pharmacological reviews.

[14]  W. Turski,et al.  Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks , 1990, Neuropharmacology.

[15]  L. Butcher,et al.  Cholinergic-dopaminergic interactions in cognitive performance. , 1990, Behavioral and neural biology.

[16]  R. J. Boegman,et al.  N-Methyl-d-aspartate-evoked release of acetylcholine from the medial septum/diagonal band of rat brain , 1990, Neuroscience Letters.

[17]  J. Vignon,et al.  In vivo labeling of phencyclidine (PCP) receptors with 3H‐TCP in the mouse brain , 1990, Journal of neuroscience research.

[18]  B. Martin,et al.  JO 1784, a potent and selective ligand for rat and mouse brain σ‐sites , 1990 .

[19]  C. Montigny,et al.  N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors , 1990 .

[20]  S. Iversen,et al.  The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. , 1989, European journal of pharmacology.

[21]  J. Penney,et al.  Anatomic correlation of NMDA and 3H-TCP-labeled receptors in rat brain , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[22]  Kenneth M. Johnson,et al.  Classification and nomenclature of phencyclidine and sigma receptor sites , 1987, Trends in Neurosciences.

[23]  E D Levin,et al.  Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. , 1987, Behavioral and neural biology.

[24]  L. Snell,et al.  Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens , 1987, Neuropharmacology.

[25]  M. Sonders,et al.  1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Snell,et al.  Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. , 1986, The Journal of pharmacology and experimental therapeutics.

[27]  D. Fage,et al.  Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat , 1986, Brain Research.

[28]  D. Lodge,et al.  Effect of ketamine on amino acid-evoked release of acetylcholine from rat cerebral cortex in vitro , 1985, Neuroscience Letters.

[29]  S. Tam,et al.  Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Snyder,et al.  Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Lodge,et al.  The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate , 1983, British journal of pharmacology.

[32]  R. Zukin,et al.  Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites. , 1981, Molecular pharmacology.

[33]  R. Stevens.  Scopolamine impairs spatial maze performance in rats , 1981, Physiology & Behavior.

[34]  H. Mclennan,et al.  The antagonism of amino acid-induced excitation of spinal neurones in the cat , 1979, Brain Research.

[35]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[36]  W. Bowen,et al.  A proposal for the classification of sigma binding sites. , 1992, Trends in pharmacological sciences.

[37]  Duncan P. Taylor,et al.  Potential antipsychotic BMY 14802 selectively binds to sigma sites , 1987 .

[38]  G. Lynch,et al.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.

[39]  J. Rossier,et al.  Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks , 1986, Nature.

[40]  C. Kilts,et al.  BW234: A nondopamine receptor‐blocking antipsychotic drug without extrapyramidal side effects? , 1985 .

[41]  G. Collingridge,et al.  Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus. , 1983, The Journal of physiology.